Joseph Edgar Craft MD
Paul B. Beeson Professor of Medicine (Rheumatology) and Professor of Immunobiology; Section Chief, Rheumatology; Program Director, Investigative Medicine; Paul B. Beeson Professor of Medicine
Departments & OrganizationsYale Combined Program in the Biological and Biomedical Sciences (BBS): Immunology | Molecular Medicine, Pharmacology, and Physiology
Yale Medical Group
Office of Student ResearchClinical Investigation, Yale Center for (YCCI): Educational Program: IMPCancer ImmunologyImmunobiology: HTIInternal Medicine: RheumatologyImmunology and Immunotherapy
Dr. Joseph Craft is Paul B. Beeson Professor of Medicine and Chief of the Section of Rheumatology, and Professor of Immunobiology at the Yale University School of Medicine. He received his undergraduate degree in chemistry from the University of North Carolina at Chapel Hill, and is a graduate of the University of North Caroline School of Medicine. Dr. Craft then did postgraduate training in medicine and in rheumatology and immunology at Yale, and has been on the faculty at that institution since 1985. At Yale, he teaches graduate and medical students, and directs a research laboratory devoted to understanding T lymphocyte differentiation and function in normal and autoimmune responses. His research has been continually supported by the National Institutes of Health since 1985, where he is a past NIH MERIT award recipient, and he is the author of 168 scientific publications. Dr. Craft is Director of the Investigative Medicine Program at Yale, a unique program designed to provide Ph.D. training for physicians. He also is a Fellow of the American Association for the Advancement of Science and a member of the American Society for Clinical Investigation and the Kunkel Society, and a member of the Board of Directors of the Lupus Foundation of America, Connecticut Chapter. He is former chair of the Immunological Sciences Study Section at NIH, and of the Scientific Advisory Board of the Alliance for Lupus Research, and a former Pew Scholar in the Biomedical Sciences. He is a co-founder of L2Diagnostics, a company in New Haven formed in partnership with Yale University and devoted to discovery of new diagnostics in vector-borne diseases and of targets for vaccine development, and is currently a member of its Board of Directors.
- M.D., University of North Carolina , 1977